Centre for Crop Health, University of Southern Queensland, Toowoomba, 4350, QLD, Australia.
Plant Dis. 2018 Mar;102(3):473-482. doi: 10.1094/PDIS-06-17-0911-FE. Epub 2018 Jan 24.
The Australian sugar industry has never pursued genetic resistance to ratoon stunting disease (RSD), despite it being widely considered to be one of the most important diseases of sugarcane (Saccharum interspecific hybrids). This is because of a prevailing view that the disease is economically managed, and that no further action needs to take place. However, there is a range of epidemiological evidence that suggests that RSD is having a more significant impact than what is generally recognized. This review traces the factors that have led to an industry stance that is apparently without any scientific justification, and which has tended to downplay the significance of RSD on Australian sugarcane productivity, and thus has led to significant lost production. The consequences of this position are that RSD may be influencing broad but poorly explained issues such as commercial ratooning performance of existing varieties and the "yield decline" that has been subject to much scrutiny, if not much success in resolving the issue. Based on the available information, this review calls on the Australian sugar industry to prioritize selection for RSD resistance in the plant improvement program.
澳大利亚糖业从未寻求对宿根矮化病(RSD)的遗传抗性,尽管它被广泛认为是甘蔗(甘蔗种间杂种)最重要的疾病之一。这是因为普遍认为该疾病在经济上是可管理的,不需要采取进一步的行动。然而,有一系列的流行病学证据表明,RSD 的影响比普遍认识的要大。本综述追溯了导致业界采取这种明显没有任何科学依据的立场的因素,这种立场往往淡化了 RSD 对澳大利亚甘蔗生产力的重要性,从而导致了重大的产量损失。这种立场的后果是,RSD 可能会影响到广泛但解释不清的问题,例如现有品种的商业宿根性能和“减产”,这一问题已经受到了大量的关注,如果不是在解决这一问题上取得了很大的成功的话。基于现有信息,本综述呼吁澳大利亚糖业在植物改良计划中优先选择对 RSD 抗性的选择。